CRISPR/Cas9 technology in restoring dystrophin expression in iPSC-derived muscle progenitors

Yue Jin, Yan Shen, Xuan Su, Neal Weintraub, Yaoliang Tang

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Duchenne muscular dystrophy (DMD) is a severe progressive muscle disease caused by mutations in the dystrophin gene, which ultimately leads to the exhaustion of muscle progenitor cells. Clustered regularly interspaced short palindromic repeats/CRISPR-associated 9 (CRISPR/ Cas9) gene editing has the potential to restore the expression of the dystrophin gene. Autologous induced pluripotent stem cells (iPSCs)-derived muscle progenitor cells (MPC) can replenish the stem/progenitor cell pool, repair damage, and prevent further complications in DMD without causing an immune response. In this study, we introduce a combination of CRISPR/Cas9 and non-integrated iPSC technologies to obtain muscle progenitors with recovered dystrophin protein expression. Briefly, we use a non-integrating Sendai vector to establish an iPSC line from dermal fibroblasts of Dmdmdx mice. We then use the CRISPR/Cas9 deletion strategy to restore dystrophin expression through a non-homologous end joining of the reframed dystrophin gene. After PCR validation of exon23 depletion in three colonies from 94 picked iPSC colonies, we differentiate iPSC into MPC by doxycycline (Dox)-induced expression of MyoD, a key transcription factor playing a significant role in regulating muscle differentiation. Our results show the feasibility of using CRISPR/Cas9 deletion strategy to restore dystrophin expression in iPSC-derived MPC, which has significant potential for developing future therapies for the treatment of DMD.

Original languageEnglish (US)
Article numbere59432
JournalJournal of Visualized Experiments
Issue number151
StatePublished - 2019


  • CRISPR/Cas9
  • DMD
  • Developmental Biology
  • Differentiation
  • Dystrophin
  • IPSC
  • Induced pluripotent stem cells
  • Issue 151
  • Myogenic progenitor

ASJC Scopus subject areas

  • Neuroscience(all)
  • Chemical Engineering(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)


Dive into the research topics of 'CRISPR/Cas9 technology in restoring dystrophin expression in iPSC-derived muscle progenitors'. Together they form a unique fingerprint.

Cite this